Journal of Endocrinological Investigation

, Volume 24, Issue 8, pp 642–643 | Cite as

Pseudohypoparathyroidism with normocalcemia

  • N. Özbey
Letter to the Editor
First Online:
Accepted:
  • 24 Downloads

Keywords

ACTH Stimulation Test Pseudohypoparathyroidism Accelerate Bone Turnover Monogenic Obesity Average Adult Height 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Bastepe M.J., Jüppner H. Pseudohypoparathyroidism. New insights into an old disease. Endocrinol. Metab. Clin. North Am. 2000, 29: 569–589.PubMedCrossRefGoogle Scholar
  2. 2.
    Miric A., Vechio J.D., Levine M.A. Heterogeneous mutations in the gene encoding the a-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J. Clin. Endocrinol. Metab. 1993, 76: 1560–1568.PubMedGoogle Scholar
  3. 3.
    Ringel M.D., Schwindinger W.F., Levine M.A. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine 1996, 75: 171–184.PubMedCrossRefGoogle Scholar
  4. 4.
    Yokoyama M., Takeda K., Iyota K., Okabayashi T., Hashimoto K. A 4-base pair deletion mutation of Gs-α gene in a Japanese patient with pseudohypoparathyroidism. J. Endocrinol. Invest. 1996, 19: 236–241.PubMedGoogle Scholar
  5. 5.
    Fitch N. Albright’s hereditary osteodystrophy: a review. Am. J. Med. Gen. 1982, 11: 11–29.CrossRefGoogle Scholar
  6. 6.
    Ong K.K.L., Amin R., Dunger D.B. Pseudohypoparathyroidism — another monogenic obesity syndrome. Clin. Endocrinol. (Oxf.) 2000, 52: 389–391.CrossRefGoogle Scholar
  7. 7.
    Breslau L.A., Zerwekh J.E. Relationship of estrogen and pregnancy to calcium homeostasis in pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 1986, 62: 45–51.PubMedCrossRefGoogle Scholar
  8. 8.
    Breslau N.A., Notman D.D., Canterbury J.M., Moses A.M. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism. Am. J. Med. 1980, 68: 856–860.PubMedCrossRefGoogle Scholar
  9. 9.
    Drezner M.A., Haussler M.R. Normocalcemic pseudohypoparathyroidism. Association with normal vitamin D3 metabolism. Am. J. Med. 1979, 66: 503–508.PubMedCrossRefGoogle Scholar
  10. 10.
    Frame B., Hanson C.A., Frost H.M., Block M., Arnstein A.R. Renal resistance to parathyroid hormone with osteitis fibrosa. “Pseudohypohyperparathyroidism”. Am. J. Med. 1972, 52: 311–321.PubMedCrossRefGoogle Scholar
  11. 11.
    Ish-Shalom S., Rao L.G., Levine M.A., Frase D., Kooh S.W., Josse R.G., McBroom R., Wong M.M., Murray T.M. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism. J. Bone Miner. Res. 1996, 11: 8–14.PubMedCrossRefGoogle Scholar
  12. 12.
    Tsang R.C., Venkataraman P., Ho M., Steichen J.J., Whitsett J., Greer F. The development of pseudohypoparathyroidism. Involvement of progressively increasing serum parathyroid hormone concentrations, increased 1,25-dihydroxyvitamin D concentrations, and “migratory” subcutaneous calcifications. Am. J. Dis. Child. 1984, 138: 654–658.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2001

Authors and Affiliations

  • N. Özbey
    • 1
  1. 1.Department of Internal Medicine Division of Endocrinology Istanbul Faculty of MedicineUniversity of IstanbulIstanbulTurkey

Personalised recommendations